Copyright Reports & Markets. All rights reserved.

Global Plasmid Manufacture Market 2025 by Company, Regions, Type and Application, Forecast to 2031

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Plasmid Manufacture by Type
    • 1.3.1 Overview: Global Plasmid Manufacture Market Size by Type: 2020 Versus 2024 Versus 2031
    • 1.3.2 Global Plasmid Manufacture Consumption Value Market Share by Type in 2024
    • 1.3.3 Preclinical Plasmid
    • 1.3.4 Clinical Plasmid
    • 1.3.5 Commercial Plasmid
  • 1.4 Global Plasmid Manufacture Market by Application
    • 1.4.1 Overview: Global Plasmid Manufacture Market Size by Application: 2020 Versus 2024 Versus 2031
    • 1.4.2 Commercial
    • 1.4.3 Academic Research
    • 1.4.4 Others
  • 1.5 Global Plasmid Manufacture Market Size & Forecast
  • 1.6 Global Plasmid Manufacture Market Size and Forecast by Region
    • 1.6.1 Global Plasmid Manufacture Market Size by Region: 2020 VS 2024 VS 2031
    • 1.6.2 Global Plasmid Manufacture Market Size by Region, (2020-2031)
    • 1.6.3 North America Plasmid Manufacture Market Size and Prospect (2020-2031)
    • 1.6.4 Europe Plasmid Manufacture Market Size and Prospect (2020-2031)
    • 1.6.5 Asia-Pacific Plasmid Manufacture Market Size and Prospect (2020-2031)
    • 1.6.6 South America Plasmid Manufacture Market Size and Prospect (2020-2031)
    • 1.6.7 Middle East & Africa Plasmid Manufacture Market Size and Prospect (2020-2031)

2 Company Profiles

  • 2.1 Charles River
    • 2.1.1 Charles River Details
    • 2.1.2 Charles River Major Business
    • 2.1.3 Charles River Plasmid Manufacture Product and Solutions
    • 2.1.4 Charles River Plasmid Manufacture Revenue, Gross Margin and Market Share (2020-2025)
    • 2.1.5 Charles River Recent Developments and Future Plans
  • 2.2 Lonza
    • 2.2.1 Lonza Details
    • 2.2.2 Lonza Major Business
    • 2.2.3 Lonza Plasmid Manufacture Product and Solutions
    • 2.2.4 Lonza Plasmid Manufacture Revenue, Gross Margin and Market Share (2020-2025)
    • 2.2.5 Lonza Recent Developments and Future Plans
  • 2.3 Aldevron
    • 2.3.1 Aldevron Details
    • 2.3.2 Aldevron Major Business
    • 2.3.3 Aldevron Plasmid Manufacture Product and Solutions
    • 2.3.4 Aldevron Plasmid Manufacture Revenue, Gross Margin and Market Share (2020-2025)
    • 2.3.5 Aldevron Recent Developments and Future Plans
  • 2.4 Thermo Fisher Scientific
    • 2.4.1 Thermo Fisher Scientific Details
    • 2.4.2 Thermo Fisher Scientific Major Business
    • 2.4.3 Thermo Fisher Scientific Plasmid Manufacture Product and Solutions
    • 2.4.4 Thermo Fisher Scientific Plasmid Manufacture Revenue, Gross Margin and Market Share (2020-2025)
    • 2.4.5 Thermo Fisher Scientific Recent Developments and Future Plans
  • 2.5 Catalent
    • 2.5.1 Catalent Details
    • 2.5.2 Catalent Major Business
    • 2.5.3 Catalent Plasmid Manufacture Product and Solutions
    • 2.5.4 Catalent Plasmid Manufacture Revenue, Gross Margin and Market Share (2020-2025)
    • 2.5.5 Catalent Recent Developments and Future Plans
  • 2.6 The Discovery Labs
    • 2.6.1 The Discovery Labs Details
    • 2.6.2 The Discovery Labs Major Business
    • 2.6.3 The Discovery Labs Plasmid Manufacture Product and Solutions
    • 2.6.4 The Discovery Labs Plasmid Manufacture Revenue, Gross Margin and Market Share (2020-2025)
    • 2.6.5 The Discovery Labs Recent Developments and Future Plans
  • 2.7 BIOCENTRIQ
    • 2.7.1 BIOCENTRIQ Details
    • 2.7.2 BIOCENTRIQ Major Business
    • 2.7.3 BIOCENTRIQ Plasmid Manufacture Product and Solutions
    • 2.7.4 BIOCENTRIQ Plasmid Manufacture Revenue, Gross Margin and Market Share (2020-2025)
    • 2.7.5 BIOCENTRIQ Recent Developments and Future Plans
  • 2.8 FUJIFILM Diosynth Biotechnologies
    • 2.8.1 FUJIFILM Diosynth Biotechnologies Details
    • 2.8.2 FUJIFILM Diosynth Biotechnologies Major Business
    • 2.8.3 FUJIFILM Diosynth Biotechnologies Plasmid Manufacture Product and Solutions
    • 2.8.4 FUJIFILM Diosynth Biotechnologies Plasmid Manufacture Revenue, Gross Margin and Market Share (2020-2025)
    • 2.8.5 FUJIFILM Diosynth Biotechnologies Recent Developments and Future Plans
  • 2.9 Exothera
    • 2.9.1 Exothera Details
    • 2.9.2 Exothera Major Business
    • 2.9.3 Exothera Plasmid Manufacture Product and Solutions
    • 2.9.4 Exothera Plasmid Manufacture Revenue, Gross Margin and Market Share (2020-2025)
    • 2.9.5 Exothera Recent Developments and Future Plans
  • 2.10 WuXi AppTec
    • 2.10.1 WuXi AppTec Details
    • 2.10.2 WuXi AppTec Major Business
    • 2.10.3 WuXi AppTec Plasmid Manufacture Product and Solutions
    • 2.10.4 WuXi AppTec Plasmid Manufacture Revenue, Gross Margin and Market Share (2020-2025)
    • 2.10.5 WuXi AppTec Recent Developments and Future Plans
  • 2.11 Pharmaron
    • 2.11.1 Pharmaron Details
    • 2.11.2 Pharmaron Major Business
    • 2.11.3 Pharmaron Plasmid Manufacture Product and Solutions
    • 2.11.4 Pharmaron Plasmid Manufacture Revenue, Gross Margin and Market Share (2020-2025)
    • 2.11.5 Pharmaron Recent Developments and Future Plans
  • 2.12 OBiO
    • 2.12.1 OBiO Details
    • 2.12.2 OBiO Major Business
    • 2.12.3 OBiO Plasmid Manufacture Product and Solutions
    • 2.12.4 OBiO Plasmid Manufacture Revenue, Gross Margin and Market Share (2020-2025)
    • 2.12.5 OBiO Recent Developments and Future Plans
  • 2.13 Cell Therapies
    • 2.13.1 Cell Therapies Details
    • 2.13.2 Cell Therapies Major Business
    • 2.13.3 Cell Therapies Plasmid Manufacture Product and Solutions
    • 2.13.4 Cell Therapies Plasmid Manufacture Revenue, Gross Margin and Market Share (2020-2025)
    • 2.13.5 Cell Therapies Recent Developments and Future Plans
  • 2.14 AGC Biologics
    • 2.14.1 AGC Biologics Details
    • 2.14.2 AGC Biologics Major Business
    • 2.14.3 AGC Biologics Plasmid Manufacture Product and Solutions
    • 2.14.4 AGC Biologics Plasmid Manufacture Revenue, Gross Margin and Market Share (2020-2025)
    • 2.14.5 AGC Biologics Recent Developments and Future Plans
  • 2.15 Cytiva
    • 2.15.1 Cytiva Details
    • 2.15.2 Cytiva Major Business
    • 2.15.3 Cytiva Plasmid Manufacture Product and Solutions
    • 2.15.4 Cytiva Plasmid Manufacture Revenue, Gross Margin and Market Share (2020-2025)
    • 2.15.5 Cytiva Recent Developments and Future Plans
  • 2.16 Helixmith
    • 2.16.1 Helixmith Details
    • 2.16.2 Helixmith Major Business
    • 2.16.3 Helixmith Plasmid Manufacture Product and Solutions
    • 2.16.4 Helixmith Plasmid Manufacture Revenue, Gross Margin and Market Share (2020-2025)
    • 2.16.5 Helixmith Recent Developments and Future Plans
  • 2.17 ThermoGenesis
    • 2.17.1 ThermoGenesis Details
    • 2.17.2 ThermoGenesis Major Business
    • 2.17.3 ThermoGenesis Plasmid Manufacture Product and Solutions
    • 2.17.4 ThermoGenesis Plasmid Manufacture Revenue, Gross Margin and Market Share (2020-2025)
    • 2.17.5 ThermoGenesis Recent Developments and Future Plans
  • 2.18 Anemocyte
    • 2.18.1 Anemocyte Details
    • 2.18.2 Anemocyte Major Business
    • 2.18.3 Anemocyte Plasmid Manufacture Product and Solutions
    • 2.18.4 Anemocyte Plasmid Manufacture Revenue, Gross Margin and Market Share (2020-2025)
    • 2.18.5 Anemocyte Recent Developments and Future Plans
  • 2.19 CBM
    • 2.19.1 CBM Details
    • 2.19.2 CBM Major Business
    • 2.19.3 CBM Plasmid Manufacture Product and Solutions
    • 2.19.4 CBM Plasmid Manufacture Revenue, Gross Margin and Market Share (2020-2025)
    • 2.19.5 CBM Recent Developments and Future Plans
  • 2.20 Bio Elpida
    • 2.20.1 Bio Elpida Details
    • 2.20.2 Bio Elpida Major Business
    • 2.20.3 Bio Elpida Plasmid Manufacture Product and Solutions
    • 2.20.4 Bio Elpida Plasmid Manufacture Revenue, Gross Margin and Market Share (2020-2025)
    • 2.20.5 Bio Elpida Recent Developments and Future Plans
  • 2.21 Genezen
    • 2.21.1 Genezen Details
    • 2.21.2 Genezen Major Business
    • 2.21.3 Genezen Plasmid Manufacture Product and Solutions
    • 2.21.4 Genezen Plasmid Manufacture Revenue, Gross Margin and Market Share (2020-2025)
    • 2.21.5 Genezen Recent Developments and Future Plans
  • 2.22 CCRM
    • 2.22.1 CCRM Details
    • 2.22.2 CCRM Major Business
    • 2.22.3 CCRM Plasmid Manufacture Product and Solutions
    • 2.22.4 CCRM Plasmid Manufacture Revenue, Gross Margin and Market Share (2020-2025)
    • 2.22.5 CCRM Recent Developments and Future Plans
  • 2.23 RoslinCT
    • 2.23.1 RoslinCT Details
    • 2.23.2 RoslinCT Major Business
    • 2.23.3 RoslinCT Plasmid Manufacture Product and Solutions
    • 2.23.4 RoslinCT Plasmid Manufacture Revenue, Gross Margin and Market Share (2020-2025)
    • 2.23.5 RoslinCT Recent Developments and Future Plans
  • 2.24 GenScript ProBio
    • 2.24.1 GenScript ProBio Details
    • 2.24.2 GenScript ProBio Major Business
    • 2.24.3 GenScript ProBio Plasmid Manufacture Product and Solutions
    • 2.24.4 GenScript ProBio Plasmid Manufacture Revenue, Gross Margin and Market Share (2020-2025)
    • 2.24.5 GenScript ProBio Recent Developments and Future Plans
  • 2.25 Oxford BioMedica
    • 2.25.1 Oxford BioMedica Details
    • 2.25.2 Oxford BioMedica Major Business
    • 2.25.3 Oxford BioMedica Plasmid Manufacture Product and Solutions
    • 2.25.4 Oxford BioMedica Plasmid Manufacture Revenue, Gross Margin and Market Share (2020-2025)
    • 2.25.5 Oxford BioMedica Recent Developments and Future Plans
  • 2.26 Porton Pharma Solutions
    • 2.26.1 Porton Pharma Solutions Details
    • 2.26.2 Porton Pharma Solutions Major Business
    • 2.26.3 Porton Pharma Solutions Plasmid Manufacture Product and Solutions
    • 2.26.4 Porton Pharma Solutions Plasmid Manufacture Revenue, Gross Margin and Market Share (2020-2025)
    • 2.26.5 Porton Pharma Solutions Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Plasmid Manufacture Revenue and Share by Players (2020-2025)
  • 3.2 Market Share Analysis (2024)
    • 3.2.1 Market Share of Plasmid Manufacture by Company Revenue
    • 3.2.2 Top 3 Plasmid Manufacture Players Market Share in 2024
    • 3.2.3 Top 6 Plasmid Manufacture Players Market Share in 2024
  • 3.3 Plasmid Manufacture Market: Overall Company Footprint Analysis
    • 3.3.1 Plasmid Manufacture Market: Region Footprint
    • 3.3.2 Plasmid Manufacture Market: Company Product Type Footprint
    • 3.3.3 Plasmid Manufacture Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Plasmid Manufacture Consumption Value and Market Share by Type (2020-2025)
  • 4.2 Global Plasmid Manufacture Market Forecast by Type (2026-2031)

5 Market Size Segment by Application

  • 5.1 Global Plasmid Manufacture Consumption Value Market Share by Application (2020-2025)
  • 5.2 Global Plasmid Manufacture Market Forecast by Application (2026-2031)

6 North America

  • 6.1 North America Plasmid Manufacture Consumption Value by Type (2020-2031)
  • 6.2 North America Plasmid Manufacture Market Size by Application (2020-2031)
  • 6.3 North America Plasmid Manufacture Market Size by Country
    • 6.3.1 North America Plasmid Manufacture Consumption Value by Country (2020-2031)
    • 6.3.2 United States Plasmid Manufacture Market Size and Forecast (2020-2031)
    • 6.3.3 Canada Plasmid Manufacture Market Size and Forecast (2020-2031)
    • 6.3.4 Mexico Plasmid Manufacture Market Size and Forecast (2020-2031)

7 Europe

  • 7.1 Europe Plasmid Manufacture Consumption Value by Type (2020-2031)
  • 7.2 Europe Plasmid Manufacture Consumption Value by Application (2020-2031)
  • 7.3 Europe Plasmid Manufacture Market Size by Country
    • 7.3.1 Europe Plasmid Manufacture Consumption Value by Country (2020-2031)
    • 7.3.2 Germany Plasmid Manufacture Market Size and Forecast (2020-2031)
    • 7.3.3 France Plasmid Manufacture Market Size and Forecast (2020-2031)
    • 7.3.4 United Kingdom Plasmid Manufacture Market Size and Forecast (2020-2031)
    • 7.3.5 Russia Plasmid Manufacture Market Size and Forecast (2020-2031)
    • 7.3.6 Italy Plasmid Manufacture Market Size and Forecast (2020-2031)

8 Asia-Pacific

  • 8.1 Asia-Pacific Plasmid Manufacture Consumption Value by Type (2020-2031)
  • 8.2 Asia-Pacific Plasmid Manufacture Consumption Value by Application (2020-2031)
  • 8.3 Asia-Pacific Plasmid Manufacture Market Size by Region
    • 8.3.1 Asia-Pacific Plasmid Manufacture Consumption Value by Region (2020-2031)
    • 8.3.2 China Plasmid Manufacture Market Size and Forecast (2020-2031)
    • 8.3.3 Japan Plasmid Manufacture Market Size and Forecast (2020-2031)
    • 8.3.4 South Korea Plasmid Manufacture Market Size and Forecast (2020-2031)
    • 8.3.5 India Plasmid Manufacture Market Size and Forecast (2020-2031)
    • 8.3.6 Southeast Asia Plasmid Manufacture Market Size and Forecast (2020-2031)
    • 8.3.7 Australia Plasmid Manufacture Market Size and Forecast (2020-2031)

9 South America

  • 9.1 South America Plasmid Manufacture Consumption Value by Type (2020-2031)
  • 9.2 South America Plasmid Manufacture Consumption Value by Application (2020-2031)
  • 9.3 South America Plasmid Manufacture Market Size by Country
    • 9.3.1 South America Plasmid Manufacture Consumption Value by Country (2020-2031)
    • 9.3.2 Brazil Plasmid Manufacture Market Size and Forecast (2020-2031)
    • 9.3.3 Argentina Plasmid Manufacture Market Size and Forecast (2020-2031)

10 Middle East & Africa

  • 10.1 Middle East & Africa Plasmid Manufacture Consumption Value by Type (2020-2031)
  • 10.2 Middle East & Africa Plasmid Manufacture Consumption Value by Application (2020-2031)
  • 10.3 Middle East & Africa Plasmid Manufacture Market Size by Country
    • 10.3.1 Middle East & Africa Plasmid Manufacture Consumption Value by Country (2020-2031)
    • 10.3.2 Turkey Plasmid Manufacture Market Size and Forecast (2020-2031)
    • 10.3.3 Saudi Arabia Plasmid Manufacture Market Size and Forecast (2020-2031)
    • 10.3.4 UAE Plasmid Manufacture Market Size and Forecast (2020-2031)

11 Market Dynamics

  • 11.1 Plasmid Manufacture Market Drivers
  • 11.2 Plasmid Manufacture Market Restraints
  • 11.3 Plasmid Manufacture Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 Plasmid Manufacture Industry Chain
  • 12.2 Plasmid Manufacture Upstream Analysis
  • 12.3 Plasmid Manufacture Midstream Analysis
  • 12.4 Plasmid Manufacture Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Plasmid Manufacture market size was valued at US$ million in 2024 and is forecast to a readjusted size of USD million by 2031 with a CAGR of %during review period.
    The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
    This report is a detailed and comprehensive analysis for global Plasmid Manufacture market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Plasmid Manufacture market size and forecasts, in consumption value ($ Million), 2020-2031
    Global Plasmid Manufacture market size and forecasts by region and country, in consumption value ($ Million), 2020-2031
    Global Plasmid Manufacture market size and forecasts, by Type and by Application, in consumption value ($ Million), 2020-2031
    Global Plasmid Manufacture market shares of main players, in revenue ($ Million), 2020-2025
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Plasmid Manufacture
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Plasmid Manufacture market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Charles River, Lonza, Aldevron, Thermo Fisher Scientific, Catalent, The Discovery Labs, BIOCENTRIQ, FUJIFILM Diosynth Biotechnologies, Exothera, WuXi AppTec, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market segmentation
    Plasmid Manufacture market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Preclinical Plasmid
    Clinical Plasmid
    Commercial Plasmid
    Market segment by Application
    Commercial
    Academic Research
    Others
    Market segment by players, this report covers
    Charles River
    Lonza
    Aldevron
    Thermo Fisher Scientific
    Catalent
    The Discovery Labs
    BIOCENTRIQ
    FUJIFILM Diosynth Biotechnologies
    Exothera
    WuXi AppTec
    Pharmaron
    OBiO
    Cell Therapies
    AGC Biologics
    Cytiva
    Helixmith
    ThermoGenesis
    Anemocyte
    CBM
    Bio Elpida
    Genezen
    CCRM
    RoslinCT
    GenScript ProBio
    Oxford BioMedica
    Porton Pharma Solutions
    Market segment by regions, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
    South America (Brazil, Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 13 chapters:
    Chapter 1, to describe Plasmid Manufacture product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top players of Plasmid Manufacture, with revenue, gross margin, and global market share of Plasmid Manufacture from 2020 to 2025.
    Chapter 3, the Plasmid Manufacture competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
    Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2020 to 2031
    Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2020 to 2025.and Plasmid Manufacture market forecast, by regions, by Type and by Application, with consumption value, from 2026 to 2031.
    Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
    Chapter 12, the key raw materials and key suppliers, and industry chain of Plasmid Manufacture.
    Chapter 13, to describe Plasmid Manufacture research findings and conclusion.

    Buy now